Dermatofibroma
Jump to navigation
Jump to search
Dermatofibroma, abbreviated DF, is a common benign skin lesion. It is also known as benign fibrous histiocytoma and fibrous histiocytoma.
Dermatofibroma | |
---|---|
Diagnosis in short | |
| |
LM | Prominent fibrous bundles - especially at the edge of the lesion ("collagen-trapping"), loss of adnexal structures, +/-"dirty fingers" (acanthosis, basal keratinocyte hyperpigmentation) |
Subtypes | Cellular, deep penetrating, lipidized, epithelioid cell histiocytoma, fibrotic, aneurysmal, granular cell dermatofibroma, dermatofibroma with monster cells |
LM DDx | DFSP, neurofibroma, blue nevus, melanoma, esp. desmoplastic neurotropic-type, fibromatosis |
Site | skin |
| |
Other | previous trauma |
General
- Reactive process -- it is not a neoplasm.
- Usually associated with previous trauma.
- In women... usually legs.
Microscopic
Features:[1]
- Prominent fibrous bundles, especially at the edge of the lesion.
- Surrounded by spindle cells (fibroblasts).
- Usually thought of as fibroblasts surrounded by fibrous material ("collagen-trapping").
- Surrounded by spindle cells (fibroblasts).
- Lack of adnexal structures, i.e. no sweat glands, no hair.
- +/-Epidermal changes - known as "dirty fingers":[2]
- Acanthosis (thickened epithelial layer - specifically thickened stratum spinosum).
- Basal keratinocyte hyperpigmentation.
DDx:
- Dermatofibrosarcoma protuberans (DFSP) - usu. deeper, classically has adnexal structures and fat within lesion.
- Neurofibroma.
- Blue nevus.
- Melanoma, esp. desmoplastic neurotropic-type.
- Fibromatosis.
Images:
- DF (flickr.com/euthman).
- Dermatofibroma (ucsf.edu).
- DF - several images (pacificderm.org).
- DF stained with factor XIIIa (biocare.net).
Subtypes
Like all common things... there are subtypes:[3]
- Cellular.
- Deep penetrating.
- Lipidized - with foamy macrophages, hemorrhage and Touton-like giant cells.
- Epithelioid cell histiocytoma.
- Fibrotic.
- Aneurysmal - large blood filled + features of lipidized.
- Granular cell dermatofibroma.
- Dermatofibroma with monster cells.
Cellular dermatofibroma
Features:
- High cell density in the dermis - "blue" at low power.
- Collagen bundles - key feature.
Images:
IHC
- Factor XIIIa +ve.
- Usually negative in DFSP.
- CD34 -ve.
- Usually positive in DFSP.
Others:
Sign out
SKIN LESION, LEFT SHOULDER, EXCISION: - DERMATOFIBROMA.
Micro
The sections show skin with bland spindle cells interspersed between fibrous bundles. The fibrous bundles are prominent at the periphery of the lesion (collagen-trapping). Focal acanthosis is present.
The lesion does not extend to the adipose tissue. No atypia is apparent. No mitotic activity is identified.
The lesion extends to the edge of the tissue.
See also
References
- ↑ Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 492. ISBN 978-0781765275.
- ↑ BD. 13 April 2011.
- ↑ Mills, Stacey E; Carter, Darryl; Greenson, Joel K; Reuter, Victor E; Stoler, Mark H (2009). Sternberg's Diagnostic Surgical Pathology (5th ed.). Lippincott Williams & Wilkins. pp. 51. ISBN 978-0781779425.
- ↑ URL: http://www.dermpedia.org/case/cellular-dermatofibroma-mimicking-dermatofibrosarcoma-protuberans#. Accessed on: 4 February 2012.
- ↑ Abenoza P, Lillemoe T (October 1993). "CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans". Am J Dermatopathol 15 (5): 429–34. PMID 7694515.
- ↑ Goldblum JR, Tuthill RJ (April 1997). "CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma". Am J Dermatopathol 19 (2): 147–53. PMID 9129699.
- ↑ Bandarchi B, Ma L, Marginean C, Hafezi S, Zubovits J, Rasty G (March 2010). "D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans". Mod. Pathol. 23 (3): 434–8. doi:10.1038/modpathol.2009.176. PMID 20062007.
- ↑ Xu, Y.; Ogose, A.; Kawashima, H.; Hotta, T.; Ariizumi, T.; Li, G.; Umezu, H.; Endo, N. (Mar 2011). "High-level expression of podoplanin in benign and malignant soft tissue tumors: immunohistochemical and quantitative real-time RT-PCR analysis.". Oncol Rep 25 (3): 599-607. doi:10.3892/or.2011.1141. PMID 21234520.